TCTR20200710005已完成2 期
Prospective, open-label study of progesterone to manage seizure in Drug resistant epilepsy
Department of Pharmacy, Faculty of pharmacy, Silpakorn university0 个研究点目标入组 19 人开始时间: 2020年7月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 19
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 Years 至 N/A (No limit)(—)
- 性别
- All
入选标准
- •Lennox-Gastaut syndrome diagnosis
- •- 12 years and older
- •- at least 2 antiepileptic drugs treatment (each at least 2 weeks)
- •- seizure frequency more than 5 times per month for more than 1 year
- •- learning or mental retardation
排除标准
- •- do not have caregiver
- •- not cooperated
- •- pregnancy
- •- during any hormone treatment
- •- CHA2DS2-VASc at least 3 scores
- •- history of stroke or myocardial infarction in 1 year
- •- AST/ALT elevation 3 folds or more from upper limit of normal (ULN) in 3 months
- •- abnormal renal function eGFR less than 30 mL/min
- •- during penicillins treatment
- •- any cancer diagnosis
- •- progesterone allergy
- •- any history of uncommon vaginal bleeding
研究者
相似试验
已完成
3 期
An open-label, randomized, controlled study of peginterferon alpha-2a/ribavirin plus meloxicam treatment for the patients with genotype 1 chronic hepatitis C (COMET study)chronic hepatitis CJPRN-UMIN000001122Tokai University School of Medicine60
已完成
不适用
Management of stroke & paralysis by ayurvedaCTRI/2017/12/011052KLE BMK Ayurveda Mahavidyalaya Shapur Belgavii10
进行中(未招募)
1 期
Prospective, randomized study of the efficacy of photodynamic therapy in actinic keratosis - PDT in AKEUCTR2008-000459-88-DEniv.-Prof. Dr. Hans F. Merk, Dept. of Dermatology, University Hospital, RWTH Aachen University100
已完成
不适用
Open-label trial to evaluate the efficacy of pre-emptive therapy with minocycline and multidisciplinary intervention for skin toxicity of anti EGFR antibody in colorectal cancer patientcolorectal cancerJPRN-UMIN000010103St. Marianna University School of Medicine Hospital30
已完成
3 期
Thyroid in heart surgeries of childreCTRI/2019/01/017334Army Hospital Research and Referral65
